Projected Earnings Date: 2026-05-19    (Delayed quote data   2026-03-20)
Last
 29.18
Change
 ⇑ +0.15   (+0.50%)
Volume
  933,421
Open
 29.30
High
 29.30
Low
 28.42
8EMA (Daily)
 29.49
40EMA (Daily)
 32.44
50EMA (Daily)
 33.10
STO (Daily)
 24.241
MACD Hist (Daily)
 0.147
8EMA (Weekly)
 32.164
40EMA (Weekly)
 34.85
50EMA (Weekly)
 34.74
STO (Weekly)
 9.451
MACD Hist (Weekly)
 -1.235
AtriCure Inc an atrial fibrillation solutions company that provides products, professional education, and support for clinical science to reduce the economic and social burden of atrial fibrillation. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2026 OptionChance.com